基于360°碲锌镉相机的全身快速记录与常规 Anger 相机协议结果比较评估[177Lu]Lu-DOTATATE 剂量测定
15 例接受[177Lu]Lu-DOTATATE 治疗的患者在注射后 24、96、168 小时分别行 32 分钟胸腹盆腔常规 SPECT 和 18 分钟全身 CZT SPECT 记录,比较肾脏、骨髓、肝、脾及最大肿瘤的活度浓度与吸收剂量。除肝脏外各器官及肿瘤两者无显著差异,肝脏差异显著但幅度小;CZT SPECT/CT 记录时间更短且覆盖全身,更适于临床常规。
要点
- 肾脏、脾、骨髓及最大肿瘤的活度浓度与吸收剂量在常规 SPECT 与 CZT SPECT 间无显著差异。
- 肝脏活度浓度与吸收剂量两者差异显著但幅度小(均 P < 0.01)。
- CZT SPECT/CT 记录时间更短且覆盖全身,作者认为更适于临床常规。
核心结论
- 注射[177Lu]Lu-DOTATATE 后,360° CZT SPECT/CT 系统计算的活度浓度与吸收剂量总体与常规 SPECT/CT 系统相当。
- 作者认为 CZT SPECT/CT 因记录时间更短且覆盖全身,更适于临床常规。
研究设计与样本
- 研究纳入 15 例转诊接受[177Lu]Lu-DOTATATE 治疗的患者。
- 患者在注射后 24、96、168 小时分别接受 32 分钟胸腹盆腔常规 SPECT 记录和 18 分钟全身 CZT SPECT 记录。
- 设备检查顺序随机选择以避免偏倚。
- 肾脏、骨髓、肝、脾由基于人工智能的工具在 CT 图像上自动分割,最大肿瘤在 CT 或 MR 图像上手动分割。
- 通过时间积分活度曲线和体素 S 值卷积计算吸收剂量,并用 1 至 113 mL 球体的恢复系数校正部分容积效应。
主要发现
- 肾脏活度浓度与吸收剂量在常规 SPECT 与 CZT SPECT 间无显著差异:24 小时活度浓度 337.3(203.3-622.4)vs 342.7(218.2-547.8)kBq/mL,吸收剂量 0.45(0.26-0.79)vs 0.47(0.25-0.79)Gy/GBq。
- 脾活度浓度与吸收剂量无显著差异:24 小时活度浓度 340.3(171.8-703.1)vs 277.7(215.6-640.8)kBq/mL,吸收剂量 0.48(0.31-1.41)vs 0.50(0.35-1.15)Gy/GBq。
- 骨髓活度浓度与吸收剂量无显著差异:24 小时活度浓度 32.7(13.9-662.9)vs 41.1(12.4-509.6)kBq/mL,吸收剂量 0.09(0.04-1.96)vs 0.13(0.06-0.87)Gy/GBq。
- 最大肿瘤活度浓度与吸收剂量无显著差异:24 小时活度浓度 826.8(376.4-4,459.0)vs 1,116.7(447.0-6,043.3)kBq/mL,吸收剂量 1.8(0.9-5.7)vs 2.0(1.0-7.3)Gy/GBq。
- 肝脏活度浓度与吸收剂量差异显著但幅度小:24 小时活度浓度 126.2(42.7-335.9)vs 113.5(35.1-293.4)kBq/mL,吸收剂量 0.23(0.07-0.72)vs 0.21(0.05-0.64)Gy/GBq,均 P < 0.01。
临床怎么用
- 作者认为 CZT SPECT/CT 因记录时间更短且覆盖全身,更适于临床常规。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Absorbed doses (ADs) may be calculated through serial conventional SPECT imaging after therapeutic [177Lu]Lu-DOTATATE injection but with recording times too long for clinical routine. The aim of this study was to determine whether activity concentrations and ADs calculated from a high-speed whole-body 360° cadmium-zinc-telluride (CZT) SPECT camera are comparable to those provided by conventional SPECT. Methods: Fifteen patients referred for [177Lu]Lu-DOTATATE treatment were enrolled and underwent, at 24, 96, and 168 h after [177Lu]Lu-DOTATATE injection, 32 min of thoracoabdominopelvic conventional SPECT recording and 18 min of whole-body CZT SPECT recording. The order of device procedure (conventional or CZT SPECT) was randomly selected to avoid bias. The kidneys, bone marrow, liver, and spleen were automatically segmented by an artificial intelligence-based tool on CT images, whereas the largest tumor was segmented manually on CT or MR images. Time-integrated activity curves were computed using activity concentrations from the kidneys, bone marrow, liver, spleen, and tumor and convolved by the voxel S-value kernel to calculate AD values. The partial-volume effect was corrected by fitting the recovery coefficients of 1- to 113-mL spheres. Activity concentrations (in Bq/mL) and ADs (in Gy/GBq) were expressed as median (minimum to maximum) and compared between the 2 cameras with Wilcoxon tests. Results: Activity concentrations and ADs were not significantly different between conventional and CZT SPECT, respectively, for the kidneys (337.3 [203.3-622.4] vs. 342.7 [218.2-547.8] kBq/mL at 24 h and 0.45 [0.26-0.79] vs. 0.47 [0.25-0.79] Gy/GBq), spleen (340.3 [171.8-703.1] vs. 277.7 [215.6-640.8] kBq/mL at 24 h and 0.48 [0.31-1.41] vs. 0.50 [0.35-1.15] Gy/GBq), bone marrow (32.7 [13.9-662.9] vs. 41.1 [12.4-509.6] kBq/mL at 24 h and 0.09 [0.04-1.96] vs. 0.13 [0.06-0.87] Gy/GBq), and largest tumor (826.8 [376.4-4,459.0] vs. 1,116.7 [447.0-6,043.3] kBq/mL at 24 h and 1.8 [0.9-5.7] vs. 2.0 [1.0-7.3] Gy/GBq). However, significant, albeit small, differences were observed for the liver (126.2 [42.7-335.9] vs. 113.5 [35.1-293.4] kBq/mL at 24 h and 0.23 [0.07-0.72] vs. 0.21 [0.05-0.64] Gy/GBq, both P < 0.01). Conclusion: Activity concentrations and absorbed doses calculated from the 360° CZT SPECT/CT system after [177Lu]Lu-DOTATATE injection are globally comparable to those obtained from a conventional SPECT/CT system. However, CZT SPECT/CT is more appropriate for clinical routine, with shorter recording times and actual whole-body coverage.
引用
- Zaragori T, Chevalier E, Citerne Q, et al. Assessment of [177Lu]Lu-DOTATATE Dosimetry from High-Speed Whole-Body Recordings Provided by a 360° Cadmium-Zinc-Telluride Camera Compared with Results from a Conventional Anger-Camera Protocol. J Nucl Med. 2025. PMID: 40113220. doi:10.2967/jnumed.124.268910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。